Tech Company Inital Public Offerings
Quotient Biodiagnostics IPO
Based in Newtown, Quotient Biodiagnostics is now a public company.
Transaction Overview
Company Name
Announced On
4/25/2014
Transaction Type
IPO
Amount
$40,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
301 South State St. S-204
Newtown, PA 18940
USA
Newtown, PA 18940
USA
Phone
Website
Email Address
Overview
Quotient Biodiagnostics (NASDAQ: QTNT) is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Cowan
Chief Technical Officer
John Allen
President
Jeremy Stackawitz
VP - Sales
Bill Brady
Browse more venture capital transactions:
Prev: 4/25/2014: Bonfyre venture capital transaction
Next: 4/25/2014: Semprius venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs